AbbVie CMO has the capability of producing your HPAPI with containment capabilities up to OEB5 (<0.1 µg/m3). These sites have more than 20 years of experience and can support a broad range of commercial GMP batch sizes including from gram scale up to 600kg. Additionally, both sites are setup with oral solid dosage (OSD) manufacturing capabilities as well and can be your end-to-end supplier. Our sites with potent handling capabilities also have commercial drug product manufacturing that allows for a smooth flow of manufacturing from a single location. This can help simplify your supply chain, remove transportation and customs headaches, and shorten supply chain lead times.
